z-logo
Premium
P4‐197: CLINICAL BENEFITS OF ORAL TRAMIPROSATE IN APOE4/4 HOMOZYGOTES WITH MILD ALZHEIMER'S DISEASE: RESPONDER ANALYSES FROM THE PHASE 3 NORTH AMERICAN TRIAL
Author(s) -
Abushakra Susan,
Porsteinsson Anton P.,
Sadowsky Carl H.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.018
Subject(s) - placebo , medicine , tolerability , clinical endpoint , gastroenterology , clinical trial , adverse effect , pathology , alternative medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here